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Physicochemical propertyAbstract The free fatty acid receptor 1 (FFAR1) is a class A G-protein coupled receptor and a
validated target to develop antidiabetic drugs. The present work describes the quantitative struc-
ture–activity relationship (QSAR) study of a series of 4-alkynyldihydrocinnamic acid analogs to
rationalize their FFAR1 agonist activity. The various physicochemical and structural descriptors
were derived from Molecular Operating Environment (MOE, 2011). The variable selection and
model development were carried out using Combinatorial Protocol in Multiple Linear Regressions
(CP-MLR) approach. The identiﬁed QSAR models highlighted the signiﬁcance of solvent accessible
surface area and associated hydrophobicity to the biological activity. The chemical features to
improve hydrophobicity of 4-alkynyldihydrocinnamic acid analogs have been discussed.
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The last decade witnessed a steep rise in the number of patients
with type 2 diabetes mellitus (T2DM) especially in young and
middle age individuals. The change in life style, irregular eating
habits and lack of exercise are contributing factors for the
development of T2DM. According to World Health Organiza-
tion approximately, 347 million people worldwide are affected
with diabetes. Here, T2DM alone accounts for more than 90%
of total diabetes. It is estimated that the diabetes will be the 7th
leading cause of death in 2030 (WHO, 2014). The T2DM is
characterized by persistent hyperglycemia due to reduced insu-
lin sensitivity, development of insulin resistance or impaired
insulin secretion. If untreated, the hyperglycemia leads to thec agents:
2 Rinnie et al.serious pathological conditions such as coronary heart disease,
atherosclerosis, nephropathy, neuropathy and retinopathy.
T2DM is a major concern in patients with cardiovascular dis-
ease because cardiovascular deaths have been increased up to
fourfold in diabetic patients when compared with their nondi-
abetic counterparts (Inzucchi and Sherwin, 2005). Several clas-
ses of drugs such as biguanide (metformin), sulphonylureas
(gliclazide), thiazolidinediones (rosiglitazone), dipeptidyl
peptidase-4 enzyme inhibitors (sitagliptin) are used as oral
hypoglycemic agents, however, use of these drugs is often asso-
ciated with serious risk factors (Stein et al., 2013). The bigua-
nides and sulphonylureas force the b-cell to secrete insulin
regardless of blood glucose levels and thus produce hypoglyce-
mia. The hypoglycemia may lead to the loss of conscious (Tan
et al., 2008; Graveling and Frier, 2009). These drugs also cause
the loss of islet function (Maedler et al., 2005; Del Guerra
et al., 2005). The side effects of mostly used thiazolidinediones
also include ﬂuid retention, weight gain, bone fracture and car-
diovascular failure (Rizos et al., 2009). These drugs are also
reported to be failed in providing desire hypoglycemic effect
for the adequate duration of time (Kahn et al., 2006; Grant
et al., 2007). Therefore, the development of new and effective
antidiabetic drugs with improved patient compliance is of cur-
rent interest (Waugh et al., 2010).
The free fatty acid receptor 1 (FFAR1 or GPR40) is a
G-coupled, class A G-protein coupled receptor. FFAR1 is
expressed in pancreatic b-cells and its activation by medium
and longer chain free fatty acids (FFAs; endogenous ligands
for FFAR1) results in enhancement of glucose stimulated insu-
lin secretion (GSIS) (Itoh et al., 2003; Briscoe et al., 2003;
Rayasam et al., 2007). The FFAR1 has been suggested as a
potential drug target for T2DM. The studies have shown that
FFAR1 agonists induce insulin secretion only when needed
and thus prevent the patient from severe hypoglycemia (Tan
et al., 2008; Feng et al., 2012). The various selective ligands
including thiazolidinedione ‘‘glitazone’’ have been identiﬁed
as FFAR1 agonists and antidiabetic agents (Kotarsky et al.,
2003; Bharate et al., 2009).
Christiansen et al. (2011) synthesized a series of
4-alkynyldihydrocinnamic acid (hereafter referred as ADCA
analogs) as FFAR1 agonists and antidiabetic agents (Table 1).
These ADCA analogs have been prepared by modifying the
ring B with substituted aryl and heteroaryls with an aim to
optimize their lipophilicity for better activity (Table 1). These
compounds have been evaluated for their efﬁcacy to stimulate
FFAR1 (Christiansen et al., 2011).
The quantitative structure–activity relationship (QSAR)
study helps to optimize the desired physicochemical property(s)
in a series of compound to improve their potency. The QSAR
study assists medicinal chemists to select the optimum struc-
tural requirement to improve the activity of a series of com-
pounds under investigation (Hansch et al., 2002). In QSAR
study, the parameterization of chemical structure plays an
essential role. In enumeration of chemical structures, it is
important to note that in isolation, a data point is only a qual-
iﬁed number. A collection of such qualiﬁed numbers makes a
variable or descriptor. In mathematical models each and every
(independent; X) variable communicates with the target
(dependent;Y) variable. A meaningful communication between
X and Y variables results in the evolution of models with
predictive value (Gupta and Prabhakar, 2008).Please cite this article in press as: Rinnie, et al., QSAR study on 4-alkynyldihydrocin
Rationales to improve activity. Arabian Journal of Chemistry (2014), http://dx.doi.In this milieu, we have contemplated a QSAR study on
FFAR1 stimulating activity of ADCA analogs. The aim of
the study was to identify the speciﬁc physicochemical and struc-
tural requirement to improve the activity of ADCA analogs.
For QSAR study, different physicochemical and structural
descriptors have been calculated from the Molecular Operating
Environment (MOE, 2011). The Combinatorial Protocol in the
Multiple Linear Regression (CP-MLR) approach was used to
develop the QSAR models (Prabhakar, 2003).
2. Material and methods
2.1. Dataset
A series of 4-alkynyldihydrocinnamic acid analogs (ADCA
analogs) along with their FFAR1 stimulating activity in terms
of pEC50 (negative logarithm of effective concentration which
showed 50% activity) was selected for the study. The structure
database of compounds was developed in MOE. The 3D struc-
tures were optimized by MMFF94x force-ﬁeld as implemented
in MOE. The optimized structure dataset was used for the
parameterization of compounds. This has resulted in three hun-
dred and seven non-zero descriptors depicting the physicochem-
ical and topological properties of the ADCA analogs. The
structure dataset was partitioned into training set (24 com-
pounds) and test set (8 compounds) with the help of single link-
age hierarchical clustering of all the descriptors (Table 1). A plot
of molecular weights (MW) versus LogP of all ADCA analogs
was used to compare the chemical space spanned by the training
set and test set compounds (Fig. 1). The plot showed that the
test set compounds cover almost entire chemical space corre-
sponding to the training set compounds.
2.2. QSAR procedure
The QSAR models were developed using the CP-MLR proce-
dure (Prabhakar, 2003). CP-MLR helps in identifying the infor-
mation rich descriptors correspond to the biological activity
under study from a large descriptor pool. It is a ﬁlter based var-
iable selection procedure for QSAR and QSPR studies
(Prabhakar, 2003; Gupta and Prabhakar, 2006; Saquib et al.,
2007). Its implementation and detailed procedural aspects are
given elsewhere (Gupta et al., 2005; Saquib et al., 2007;
Prabhakar et al., 2006; Gupta and Prabhakar, 2008; Sharma
et al., 2011;Kumar et al., in press). InCP-MLR, the ﬁlter-1 seeds
the variables by the way of limiting inter-parameter correlations
to a predeﬁned level (default acceptable value60.3); ﬁlter-2 con-
trols the variables entry to a regression equation through t-val-
ues of coefﬁcients (threshold value P2.0) which confer more
than 95% regression coefﬁcients signiﬁcant level ; ﬁlter-3
provides comparability of equations with different numbers of
variables in terms of square-root of adjusted multiple correla-
tion coefﬁcient of regression equation ‘‘r-bar’’ and ﬁlter-4 esti-
mates the consistency of the equation in terms of cross-
validated R2 or Q2. In the present study, the thresholds for ﬁl-
ters-1, 2, 3 and 4 were kept 0.3, 2.0, 0.71 and 0.3 6 Q2 6 1.0,
respectively. Reassessment of the identiﬁed models was done
for chance correlations by performing repeated randomization
of the activity. Each identiﬁed model was subjected to 100
simulation runs with scrambled activity and the emergingnamic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents:
org/10.1016/j.arabjc.2014.11.047










Obsd. Eq. (1) Eq. (2) Eq. (3)
1 -phenyl 6.70 6.820 7.148 6.898
2a -pyridin-2-yl 4.88 5.568 5.251 5.607
3 -pyridin-3-yl 5.22 5.637 5.656 5.675
4 -pyridin-4-yl 5.39 5.677 5.914 5.654
5 -6-methylpyridin-2-yl 5.21 5.857 5.441 5.777
6 -3-nitropyridin-2-yl 4.96 4.674 4.614 4.906
7 -2-chloropyridin-3-yl 6.22 6.355 6.005 6.460
8 -6-chloropyridin-3-yl 6.15 6.280 6.241 6.467
9 -2-ﬂuoro-5-methylpyridin-3-yl 6.18 6.759 5.940 6.684
10 -2-chloropyrimidin-4-yl 5.04 5.160 5.487 5.256
11 -2-methoxypyrimidin-4-yl 5.02 4.956 5.085 4.431
12 -2-chloro-5-methylpyrimidin-4-yl 5.37 5.509 5.486 5.350
13 -2-chloro-6-methylpyrimidin-4-yl 5.56 5.437 5.462 5.314
14 -thiazol-5-yl 5.41 5.567 5.877 5.425
15a -thiophen-2-yl 6.60 6.736 7.139 6.636
16 -3-methylthiophen-2-yl 7.12 7.084 7.263 6.669
17 -o-tolyl 7.34 7.046 7.039 6.901
18a -2-methyl-pyridin-4-yl 5.95 5.828 5.882 5.763
19 -2-ﬂuoropyridin-4-yl 6.29 6.259 6.816 6.423
20a -2-chloropyridin-4-yl 6.53 6.353 6.389 6.458
21 -2-methoxypyridin-4-yl 6.28 6.090 5.490 5.770
22 -2-phenoxypyridin-4-yl 6.32 5.522 5.946 6.754
23 -2-phenyl-pyridin-4-yl 6.73 6.194 6.111 6.422
24a -2-o-tolylpyridin-4-yl 5.97 6.285 6.347 6.672
25a -2-ﬂuoro-5-methylpyridin-4-yl 6.75 6.606 6.689 6.515
26 -2-ﬂuoro-3-methylpyridin-4-yl 6.92 6.372 6.569 6.285
27 -2-chloro-3-methylpyridin-4-yl 6.87 6.601 6.531 6.552
28 -3-allyl-2-chloropyridin-4-yl 6.50 7.479 6.751 6.930
29a -7-chloroquinolin-4-yl 7.10 6.955 6.699 6.935
30 -2,6-dichloropyridin-4-yl 7.39 6.874 7.170 7.246
31a -2,6-dichloro-3-methylpyridin-4-yl 7.36 7.355 7.410 7.410
32d -2,6-dichloropyridin-4-yl 7.37 7.341 7.501 7.125
a Test set compounds.
b Observed activity.
c Predicted activity by corresponding equation.
d Compound with a cyclopropane ring at a b carbons of parent structure.
QSAR study on 4-alkynyldihydrocinnamic acid analogs 3correlations were counted to express the percent chance correla-
tion of the model under examination (Prabhakar et al., 2004).
The proposed models were validated through test set. The
robustness of models was further evaluated by calculating their
overall metric values (Ojha et al., 2011; Roy et al., 2012) and
slopes (k and k0) for the least squares regression line (Golbraikh
and Tropsha) (Table 2). The metric is represented by the follow-
ing equation:




Here r2 and r20 are correlations between the observed and pre-
dicted values with and without intercept, respectively, for the
least squares regression lines. The metric r2m values help to cir-
cumvent the overestimation of the quality of prediction due toPlease cite this article in press as: Rinnie, et al., QSAR study on 4-alkynyldihydrocin
Rationales to improve activity. Arabian Journal of Chemistry (2014), http://dx.doi.oa wide response range (Y-range) (Ojha et al., 2011; Roy et al.,








Here, Y and eY are observed and predicted activities, respec-
tively. For a good predictive QSAR model the value of k
and k0 should be near to 1 (Golbraikh and Tropsha, 2002).3. Results and discussion
In the ﬁrst step of the study, CP-MLR procedure with default
parameter settings was used to develop simple one and twonamic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents:
rg/10.1016/j.arabjc.2014.11.047
Figure 1 Plot of molecular weights (MW) versus logP of training
(circle) and test (triangle) set of ADCA analogs.
4 Rinnie et al.descriptor models (base line models). This resulted in identiﬁ-
cation of three one-parameter and six hundred and sixty-four
two-parameter models embedding total one hundred and
sixty-ﬁve descriptors in them. These one hundred and sixty-ﬁve
descriptors were selected to discover higher models i.e. four-
parameter models to explain the activity of ADCA analogs.
The following are selected four-parameter models (Eqs. (1)
and (2)) from the pool of equations:
logEC50 ¼ 0:661ð0:117Þa nClþ 0:601ð0:223Þa nF
 1:158ð0:128Þa nNþ 1:678ð0:501Þstd dim2
þ 4:844 ð1Þ
n ¼ 24; r ¼ 0:920 Q2ðLOOÞ ¼ 0:743; Q2ðL3OÞ ¼ 0:733;
s ¼ 0:347; F ¼ 26:403
FIT ¼ 2:640; LOF ¼ 0:215; AIC ¼ 0:184;
R2T ¼ 0:857; ryrandðSDÞ ¼ 0:424ð0:137Þ ð2Þ




n ¼ 24; r ¼ 0:920; Q2ðLOOÞ ¼ 0:781; Q2ðL3OÞ ¼ 0:752;
s ¼ 0:348; F ¼ 26:321
FIT ¼ 2:632; LOF ¼ 0:216; AIC ¼ 0:185; R2T ¼ 0:840;
ryrandðSDÞ ¼ 0:395ð0:116Þ
In all regression equations, n is number of compounds,
r is correlation coefﬁcient, Q2 is cross-validated R2 fromTable 2 Metric r2m values and slopes of QSAR models.
Equations Metric valuea






a For an acceptable QSAR model, the value of ‘‘Average r2m’’ should b
b Slope should be close to 1.
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2
from leave-three-out procedure (where a group of three com-
pounds are randomly kept outside the analysis each time in
such a way that all compounds are in the predictive groups
for once), s is standard error of the estimate and F is F-ratio
between the variances of calculated and observed activities.
The ryrand(SD) is the mean correlation coefﬁcient of the regres-
sions in the activity (Y) randomization study with its standard
deviation from 100 simulations. In the randomization study,
none of the identiﬁed models has shown any chance correla-
tion. Additional statistical parameters such as, the ‘‘Akaike’s
information criterion’’ (AIC) (Akaike, 1973, 1974), the Kub-
inyi function ‘FIT’ (Kubinyi, 1994a, 1994b) and the Fried-
man’s ‘‘lack of ﬁt’’ (LOF) (Friedman, 1990) have also been
calculated to further validate the derived QSAR models. The
AIC takes into account the statistical goodness of ﬁt and the
number of parameters that have to be estimated to achieve that
‘degree of ﬁt’. The Kubinyi function ‘FIT’ closely related to the
F-value, proved to be a useful parameter for assessing the qual-
ity of the models. The model that produces the lowest AIC
value and highest FIT value is considered potentially the most
useful. The LOF factor takes into account the number of terms
used in the equation and is not biased, as are other indicators,
toward large number of parameters (Sharma et al., 2009). The
Eqs. (1) and (2) have been validated with a test set of 8 com-
pounds (R2T = R
2 of test set compounds). The test set predic-
tions are in agreement with their experimental values (Table 1).
The metric r2m values and slopes (k and k
0) of developed models
(Eqs. (1)–(3)) have been found within their acceptable limits
and thus, ensure the good predictability of the models
(Table 2).
Now in terms of physical meaning descriptors, a_nN and
vsurf_CP (Pearson correlation r= 0.691 and 0.687, respec-
tively) are among the highest correlating descriptors with the
activity (Table 3). The a_nN refers to the number of nitrogen
atoms in ADCA analogs. Negative correlation of a_nN with
activity indicated that presence of nitrogen atom(s) in aryl
rings is detrimental for the activity. Closure look into the
structures of ADCA analogs showed that phenyl/thiophenyl
group containing analogs (compounds 1 and 15, Table 1)
exhibited better activity than nitrogen containing pyridyl (2,
3 and 4), pyrimidyl (11) and thiazolyl (14) analogs. The
descriptors a_nCl (number of chlorine atoms) and a_nF (num-
ber of ﬂuorine atoms) show positive correlation with the activ-
ity. Here, chloro (20, 30) or ﬂuoro (19) substituted pyridyl
derivatives appeared superior to the unsubstituted one (2, 3,
4). This may be suggested that the increase in activity of chloro
or ﬂuoro substituted pyridyl or pyrimidyl derivatives may be
due their positive effect on the hydrophobicity of these ana-
logs. The descriptor std_dim2 (Eq. (1)) and vsurf_CP (Eq.





0.647 0.090 0.997 0.999
0.693 0.098 0.997 0.999
0.698 0.099 1.000 0.996
e >0.5 and Dr2m should be <0.2.
namic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents:
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Table 3 Pearson correlation matrix for the descriptors correspond to the Eqs. (1)–(3).
Des. no. Descriptorsa 1 2 3 4 5 6 7 8 9
1 a_nCl 1.000
2 a_nF 0.260 1.000
3 a_nN 0.236 0.055 1.000
4 dipoleX 0.291 0.084 0.235 1.000
5 SlogP_VSA2 0.269 1.000 0.055 0.084 1.000
6 SlogP_VSA6 0.946 0.232 0.141 0.161 0.232 1.000
7 std_dim2 0.069 0.007 0.105 0.123 0.007 0.105 1.000
8 vsurf_CP 0.038 0.277 0.896 0.292 0.277 0.041 0.003 1.000
9 logP(o/w) 0.349 0.005 0.554 0.053 0.005 0.391 0.257 0.633 1.000
logEC50b 0.294 0.150 0.691 0.114 0.150 0.367 0.249 0.687 0.857
a a_nCl: number of chlorine atoms; a_nF: number of ﬂuorine atoms; a_nN: number of nitrogen atoms; dipoleX: dipole moment; SlogP_VSA2
and SlogP_VSA6: accessible van der Waals surface area associated with SlogP; std_dim2 and vsurf_CP: surface area, volume and shape
descriptor; logP(o/w): hydrophobicity.
b logIC50: Free fatty acid receptor 1 agonist activity.
Figure 2 Plots for observed versus predicted activity of training (circle) and test (triangle) set of ADCA analogs.
QSAR study on 4-alkynyldihydrocinnamic acid analogs 5volume and shape of the compounds. These descriptors are
favorable for activity. The std_dim2 depend on the structure
connectivity and conformation of compounds. The vsurf_CP
is a critical packing descriptor which considers surface and
shape of molecules. The higher surface area of molecules is
associated with either hydrophobicity or important for
dispersion interactions. Its positive correlation with activity
indicates that the descriptor is conducive for the activity.
SlogP_VSA2 and SlogP_VSA6 (Eq. (2)) are indicative of
accessible van der Waals surface area with lag 2 and 6 respec-
tively of the compounds associated with SlogP. Their positivePlease cite this article in press as: Rinnie, et al., QSAR study on 4-alkynyldihydrocin
Rationales to improve activity. Arabian Journal of Chemistry (2014), http://dx.doi.ocorrelations with the activity indicate that the compounds with
high accessible van der Waals surface area would have higher
activity. The chloro function in compound 20 has higher
accessible van der Waals surface area than ﬂuoro containing
compound 19 and exhibited better activity. However, com-
pounds 26 (ﬂuoro) and 27 (chloro) showed comparable activity
(Table 1).
The series of ADCA analogs were designed by Christiansen
et al. to study the effect of hydrophobicity. They assumed that
compounds with less hydrophobicity or high hydrophilicity
would be favorable for activity. To study the inﬂuence ofnamic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents:
rg/10.1016/j.arabjc.2014.11.047
6 Rinnie et al.hydrophobicity on the activity of ADCA analogs, the Eq. (3)
was developed by replacing parameter std_dim2 in Eq. (1) with
logP(o/w).
logEC50 ¼0:657ð0:169Þa nNþ 0:352ð0:139Þa nCl
þ 0:476ð0:213Þa nFþ 0:464ð0:120ÞlogPðo=wÞ þ 4:780
ð3Þ
n ¼ 24; r ¼ 0:929; Q2ðLOOÞ ¼ 0:785; Q2ðL3OÞ ¼ 0:783;
s ¼ 0:328; F ¼ 30:241
FIT ¼ 3:024; LOF ¼ 0:191; AIC ¼ 0:164; R2T ¼ 0:758;
ryrandðSDÞ ¼ 0:399ð0:118Þ
The logP(o/w) was found as the highest correlating descriptor
with activity (r= 0.857, Table 3). Its positive correlation with
activity of these analogs clearly indicates that hydrophobicity
is favorable for activity and thus the ADCA analogs with
hydrophobic aryl functions may exhibit superior FFAR1 ago-
nistic activity. In all equations, the test set predictions were
found to be in agreement with their observed activities (Fig. 2).
4. Concluding remarks
The QSAR study on ADCA analogs as FFAR1 agonist indi-
cated that hydrophobicity is an important physicochemical
property for their activity. Hydrophobicity of organic
molecules depends upon their solvent accessible surface area
and thus, substituted aryl functions (phenyl or thiophenyl)
with high solvent accessible surface area would lead to better
activity. In aliphatic substituents, linear one possesses more
van der Waals surface area than corresponding branched sub-
stituents. Therefore, aryl function in ADCA analogs may be
substituted with open chain alkyl groups to increase their
hydrophobicity and activity. In addition to this, aryl groups
substituted with chloro or ﬂuoro functions at ortho, meta or
para positions would show superior FFAR1 agonistic activity.
Presence of nitrogen atom decreases the hydrophobicity and
thus nitrogen containing heterocyclic ring should be avoided
for better FFAR1 agonistic activity.Acknowledgments
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